Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Hemoglobin ; 40(3): 220-2, 2016 Jun.
Article in English | MEDLINE | ID: mdl-26956672

ABSTRACT

We describe a case of delirium occurring in a hospitalized sickle cell patient. Following admission for a typical pain crisis, the patient continued to report unrelieved pain with marked agitation for several days, despite escalating doses of opioid analgesia, and ultimately required intubation following development of acute chest syndrome (ACS). After some delay, it was discovered that he had been using a synthetic cannabinoid (K2) which may have precipitated his pain crisis and, with hindsight, explained his prolonged period of delirium. Delayed recognition was due to multiple factors, notably the absence of an index of suspicion for this novel drug, the presence of alternate explanations for the patient's altered mental status, and the fact that reliable laboratory screening for synthetic cannabinoids is currently not widely available.


Subject(s)
Anemia, Sickle Cell/complications , Cannabinoids/adverse effects , Pain/etiology , Acute Chest Syndrome/etiology , Analgesics, Opioid/therapeutic use , Delirium/chemically induced , Diagnostic Errors , Humans , Male , Pain/chemically induced
SELECTION OF CITATIONS
SEARCH DETAIL
...